Oncology Med Announces a 14% Revenue Increase for Fiscal Year 2007 From the Prior Year
10 Marzo 2008 - 10:09AM
Marketwired
PITTSBURGH, PA announced its unaudited results for the fiscal
year 2007 shows a 14% increase in revenues to $ 1,745,606.00 from $
1,536,100.00 for the fiscal year ended 2006. The Company had a net
loss of only ($ 76,572.00) for the fiscal year ended 2007 as
compared to a net loss of ($ 213,310.00) for fiscal year 2006.
Dr. William J. Walker, chairman of Oncology Med, Inc., stated,
"I am extremely pleased with our results for 2007. We have achieved
a substantial increase in revenue for fiscal year 2007 over the
same period last year. We will have revenues in excess of $
2,000,000.00 for fiscal year 2008 in addition to achieving net
income for the period."
About Oncology Med, Inc.
Oncology Med is a public company engaged in the fulfillment of
services related to the treatment of various cancers. It currently
provides analysis and design of radiation treatment plans in order
for radiation oncologists to administer radiation plans to cancer
patients. Current services facilitate radiation treatment programs
ranging from external beam radiation to more advanced radiation
treatment technologies.
More information about Oncology Med, Inc. can be found at
www.oncologymed.com.
NOTE: This press release may contain "forward-looking
statements." In some cases, you can identify forward-looking
statements by terminology such as "may," "will," "should," "could,"
"expects," "plans," "intends," "anticipates," "believes,"
"estimates," "predicts," "potential," "continue" or the negative of
such terms and other comparable terminology. These forward-looking
statements include, without limitation, statements about our market
opportunity, our strategies, competition, expected activities and
expenditures as we pursue our business plan, and the adequacy of
our available cash resources. Although we believe that the
expectations reflected in any forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity,
performance or achievements. Actual results may differ materially
from the predictions discussed in these forward-looking statements.
Changes in the circumstances upon which we base our predictions
and/or forward-looking statements could materially affect our
actual results.
For information, please contact: Email Contact
Bellatora (PK) (USOTC:ECGR)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Bellatora (PK) (USOTC:ECGR)
Gráfica de Acción Histórica
De May 2023 a May 2024